Manic Disorder

7 clinical trials · Condition

Record	Firm	Date
Observational Post-Authorisation Safety Study of Asenapine (Sycrest) (NCT01734278)	Professor Saad Shakir	2012-10-01
Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder. (NCT00521365)	AstraZeneca	2008-05-01
Effects of Pentazocine Versus Lorazepam on Manic Symptoms (NCT00431184)	Mclean Hospital	2007-01-01
Phase 3 /Seroquel SR Acute Mania Monotherapy - US (NCT00422123)	AstraZeneca	2007-01-01
A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol (NCT00253162)	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2001-03-01
A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder. (NCT00250367)	Janssen Pharmaceutica N.V., Belgium	1997-10-01
A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder (NCT00253149)	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Every clearance here is in the API, with alerts when new ones post.